Modulatory efficacy of rosmarinic acid on premalignant lesions and antioxidant status in 1,2-dimethylhydrazine induced rat colon carcinogenesis

Environmental Toxicology and Pharmacology

Volumn 34, Issue 3, 2012, Pages 949-958

  Karthikkumar, V ^a   Sivagami, G ^a   Vinothkumar, R ^a   Rajkumar, D ^a   Nalini, N ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

ACF; Bacterial enzymes; Circulatory antioxidants; DMH; Rosmarinic acid

Indexed keywords

1,2 DIMETHYLHYDRAZINE; BACTERIAL ENZYME; ROSMARINIC ACID;

ABERRANT CRYPT FOCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT STATUS; ARTICLE; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; COLON FLORA; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; MALE; METABOLIC PARAMETERS; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RAT; WISTAR RAT;

1,2-DIMETHYLHYDRAZINE; ABERRANT CRYPT FOCI; ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CARCINOGENS; CINNAMATES; COLONIC NEOPLASMS; DEPSIDES; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, WISTAR;

BACTERIA (MICROORGANISMS); RATTUS;

EID: 84871738863     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2012.07.014     Document Type: Article

References (59)

1. Peanut Science and Technology 1982, 660. Am. Peanut Res. Educ. Soc., Yoakum, TX. E.M. Ahmed, C.T. Young, H.E. Pattee, C.T. Young (Eds.).
2. Aiub C., Giannerini A., Ferreira F., Mazzei J., Stankevicins L., Lobo-Hajdu G., Guimarães P., Hajdu E., Felzenszwalb I. Genotoxic evaluation of extracts from Aplysina fulva, a Brazilian marine sponge. Mutat. Res. 2006, 10:34-41.
3. Andreyev H.J.N., Norman A.R., Oates J., Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy?. Eur. J. Cancer 1998, 34:503-509.
4. Aranganathan S., Panneer Selvam J., Sangeetha N., Nalini N. Modulatory efficacy of hesperetin (citrus flavanone) on xenobiotic-metabolizing enzymes during 1,2-dimethylhydrazine-induced colon carcinogenesis. Chem.-Biol. Interact. 2009, 180:254-261.
5. Arutiunian A.V., Prokopenko V.M., Burmistrov S.O., Oparina T.I., Frolova E.V., Zabezhinski M.A., Popovich I.G., Anisimov V.N. Free-radical processes in blood serum, liver and large bowel during 1,2-dimethylhydrazine-induced carcinogenesis in rats. Vop. Onkol. 1997, 43:618-622.
6. Bae J.M., Jung K.W., Won Y.J. Estimation of cancer deaths in Korea for the upcoming years. J. Korean Med. Sci. 2002, 17:611-615.
7. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 1987, 37:147-151.
8. Bird R.P., Good C.K. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol. Lett. 2000, 112:395-402.
9. Bisaria V.S., Mishra S. Cellulase biosynthesis and regulation. CRC Crit. Rev. Biotechnol. 1989, 5:61-103.
10. Borrelli F., Izzo A.A., Di Carlo G., Maffia P., Russo A., Maiello F.M., Capasso F., Mascolo N. Effect of a propolis extract and caffeic acid phenethyl ester on formation of aberrant crypt foci and tumors in the rat colon. Fitote 2002, 73:S38-S43.
11. Bratton A.C., Marshall E.K. A new coupling component for sulfanilamide determination. J. Biol. Chem. 1939, 128:537-550.
12. Caderni G., Giannini A., Lancioni L., Luceri C., Biggeri A., Dolara P. Characterization of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis. Br. J. Cancer 1995, 71:763-769.
13. Carlberg I., Mannervik B. Glutathione reductase. Method Enzymol. 1985, 113:484-490.
14. Center M.M., Jemal A., Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol. Biomark. Prevent. 2009, 18:1688-1694.
15. Cobb W.Y., Johnson B.R. Peanut-Culture and Uses 1972, Am. Peanut Res. Educ. Assoc., Stillwater, OK, p. 210.
16. Day D.W., Jass J.R., Price A.B., Shepherd N.A., Sloan J.M., Talbot I.C., Warren B.F., Williams G.T. Morson and Dawson's Gastrointestinal Pathology 2003, Blackwell Verlag GmbH, Kurfürstendamm 57, 10707 Berlin, Germany. 4th ed.
17. Ellman G.L. Tissue sulphydryl groups. Arch. Biochem. Biophys. 1982, 82:70-77.
18. Fiala E.S. Investigations into the mechanism and mode of action of the colon carcinogens 1,2-dimethylhydrazine and azoxymethane. Cancer 1983, 40:2436-2445.
19. Fiala E.S., Joseph C., Sohn O.S., El-Bayoumy K., Reddy B.S. Mechanism of benzylselenocyanate inhibition of azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res. 1991, 51:2826-2830.
20. Folhe L., Gunzler W.A. Assays of glutathione peroxidase. Method Enzymol. 1984, 105:114-121.
21. Freeman H.J. Effects of differing purified cellulose, pectin, and hemicellulose fiber diets on fecal enzymes in 1,2-dimethylhydrazineinduced rat colon carcinogenesis. Cancer Res. 1986, 46:5529-5532.
22. Fujimitsu Y., Nakanishi H., Inada K., Yamachika T., Ichinose M., Fukami H., Tatematsu M. Development of aberrant crypt foci involves a fission mechanism as revealed by isolation of aberrant crypts. Jpn. J. Cancer Res. 1996, 87:1199-1203.
23. Giovannucci E., Rimm E.B., Stampfer M.J., Coldit G.A., Ascherio A., Willett W.C. Intake d' fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res. 1994, 54:2390-2397.
24. Giovannucci E., Stampfer M.J., Cold G., Rimm E.B., Willett W.C. Relationship of diet to risk of colorectai adenoma in man. J. Natl. Cancer Inst. 1992, 84:91-98.
25. Gold J. Cancer cachexia and gluconeogenesis. Ann. N. Y. Acad. Sci. 1974, 230:103-110.
26. Goldin B.R., Gorbach S.L. Effect of Lactobacillus acidophilus dietary supplementation on 1,2-dimethylhydrazine dihydrochloride induced intestinal cancer in rats. J. Natl. Cancer Inst. 1980, 64:263-265.
27. Gorbach S.L. Biochemical methods and experimental models for studying the intestinal flora. Ann. Ist Super Sanita 1986, 22:739-747.
28. Jen J., Powell S.M., Papadopoulos N., Smith K.J., Hamilton S.R., Vogelstein B., Kinzler K.W. Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 1994, 54:5523-5526.
29. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys. 1984, 21:130-132.
30. Karthikkumar V., Vennila S., Nalini N. Modifying effects of morin on the development of aberrant crypt foci and bacterial enzymes in experimental colon cancer. Food Chem. Toxicol. 2009, 47:309-315.
31. Lee S.M., Lee W.K. Effect of lactic acid bacteria on intestinal microbial enzyme activity and composition in rats treated with azoxymethane. J. Microbiol. 2001, 39:154-161.
32. Linden S.K., Sutton P., Karlsson N.G., Korolik V., McGuckin M.A. Mucins in the mucosal barrier to infection. Mucosal Immunol. 2008, 1:183-197.
33. McLellan E., Bird R.P. Effect of disulfiram on 1,2-dimethylhydrazine and azoxymethane-induced aberrant crypt foci. Carcinogenesis 1991, 12:969-972.
34. McLellan E.A., Medline A., Bird R.P. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res. 1991, 51:5270-5274.
35. Mohandas K.M. Colorectal cancer in India: controversies, enigmas and primary prevention. Indian J. Gastroenterol. 2011, 30:3-6.
36. Mohandas K.M., Desai D.C. Epidemiology of digestive tract cancers in India. V. Large and small bowel. Indian J. Gastroenterol. 1996, 18:118-121.
37. Nelson N. A photometric adaptation of the Somogyi method for the determination of glucose. J. Biol. Chem. 1944, 153:375-380.
38. Nicholson M.L., Neoptolemos J.P., Clayton H.A., Heagerty A.M. Diet and colorectal cancer. Int. Clin. Nutr. Rev. 1988, 8:180-197.
39. Nigro N.D., Singh D.V., Campbell R.L., Pak M.S. Effect of dietary beef fat on intestinal tumour formation by azoxymethane in rats. J. Natl. Cancer Inst. 1975, 54:439-442.
40. Ohkami H., Tazawa K., Yamashita I., Shimizu T., Murai K., Toyama K., Fujimaki M. Effects of apple pectin on fecal enzymes in azoxymethane-induced rat colon carcinogenesis. Jpn. J. Cancer Res. 1995, 86:523-529.
41. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
42. Otori K., Oda Y., Sugiyama K., Hasebe T., Mukai K., Fujii T., Tajiri H., Yoshida S., Fukushima S., Esumi H. High frequency of K-ras mutations in human colorectal hyperplastic polyps. Gut 1997, 40:660-663.
43. Patrick L. Toxic metals and antioxidants: part 2. The role of antioxidants in arsenic and cadmium toxicity. Alternat. Med. Rev. 2003, 8:106-128.
44. Reddy B.S. Dietary fat and colon cancer: animal model studies. Lipids 1992, 27:807-813.
45. Rowland I.R., Mallett A.K., Wise A. A comparison of the activity of five microbial enzymes in cecal content from rats, mice, and hamsters, and response to dietary pectin. Toxicol. Appl. Pharmacol. 1983, 69:143-148.
46. Sangeetha N., Viswanathan P., Balasubramanian T., Nalini N. Colon cancer chemopreventive efficacy of silibinin through perturbation of xenobiotic metabolizing enzymes in experimental rats. Eur. J. Pharmacol. 2012, 674:430-438.
47. Shiau S.Y., Chang G.W. Effects of dietary fiber on fecal mucinase and β-glucuronidase activity in rats. J. Nutr. 1983, 113:138-144.
48. Shiau S.Y., Ong Y.O. Effects of cellulose, agar and their mixture on colonic mucin degradation in rats. J. Nutr. Sci. Vitaminol. (Tokyo) 1992, 38:49-55.
49. Simon G., Gorbach S. The human intestinal microflora. Dig. Dis. Sci. 1986, 31:1425-1475.
50. Sinha A.K. Colorimetric assay of catalase. Anal. Biochem. 1972, 47:389-394.
51. Sohn O.S., Ishizaki H., Yang C.S., Fiala E.S. Metabolism of azoxymethane, methylazoxymethanol and N-nitrosodimethylamine by cytochrome P450 IIE1. Carcinogenesis 1991, 12:127-131.
52. Tamura K., Ishiguro S., Munakata A., Yoshida Y., Nakaji S., Sugawara K. Annual changes in colorectal carcinoma incidence in Japan. Analysis of survey data on incidence in Aomori Prefecture. Cancer 1996, 78:1187-1194.
53. Uchida H., Ando H., Maruyamak K., Kobayashi H., Toda H., Ogawa H., Ozawa T., Matsuda Y., Sugimura H., Kanno T., Baba S. Genetic alterations of mixed hyperplastic adenomatous polyps in the colon and rectum. Jpn. J. Cancer Res. 1998, 89:299-306.
54. Visconti R., Grieco D. New insights on oxidative stress in cancer. Curr. Opin. Drug Discov. Dev. 2009, 12:240-245.
55. Wei M., Morimura K., Wanibuchi H., Shen J., Doi K., Mitsuhashi M., Moku M., Salim E.I., Fukushima S. Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Cancer Lett. 2003, 202:11-16.
56. Weisburger J.H. Colon carcinogens: their metabolism and mode of action. Cancer 1971, 28:60-70.
57. Willett W.C., Stampfer M.J., Colditz G.A., Rosner B.A., Speizer F.E. Relation of meat, fat, and libel intake to the risk of colon cancer m a prospective study among women. N. Engl. J. Med. 1990, 323:1664-1672.
58. World Health Organization, Cancer, Fact sheet N°297 (accessed 02.10.11).
59. Yamashita N., Minamoto T., Ochiai A., Onda M., Esumi H. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology 1995, 108:434-440.